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ROBUST PARTIAL LIKELIHOOD APPROACH FOR DETECTING
IMPRINTING AND MATERNAL EFFECTS USING
CASE-CONTROL FAMILIES1
By Jingyuan Yang and Shili Lin
Ohio State University
Genomic imprinting and maternal effects are two epigenetic fac-
tors that have been increasingly explored for their roles in the eti-
ology of complex diseases. This is part of a concerted effort to find
the “missing heritability.” Accordingly, statistical methods have been
proposed to detect imprinting and maternal effects simultaneously
based on either a case-parent triads design or a case-mother/control-
mother pairs design. However, existing methods are full-likelihood
based and have to make strong assumptions concerning mating type
probabilities (nuisance parameters) to avoid overparametrization. In
this paper we propose to augment the two popular study designs
by combining them and including control-parent triads, so that our
sample may contain a mixture of case-parent/control-parent triads
and case-mother/control-mother pairs. By matching the case families
with control families of the same structure and stratifying according
to the familial genotypes, we are able to derive a partial likelihood
that is free of the nuisance parameters. This renders unnecessary
any unrealistic assumptions and leads to a robust procedure without
sacrificing power. Our simulation study demonstrates that our par-
tial likelihood method has correct type I error rate, little bias and
reasonable power under a variety of settings.
1. Introduction. Genomic imprinting and maternal effects are two epi-
genetic factors that have been increasingly explored for their roles in the
etiology of complex diseases. This is part of a concerted effort to find the
“missing heritability” [Manolio et al. (2009)]. Genomic imprinting (mater-
nal or paternal) is an epigenetic process involving methylation and histone
modifications in order to silence the expression of a gene inherited from a
particular parent (mother or father) without altering the genetic sequence.
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This process leads to unequal expression of a heterozygous genotype depend-
ing on whether the imprinted variant is inherited from the mother or the
father. Maternal effect, on the other hand, refers to a situation where the
phenotype of an individual is influenced by the genotype of the mother. Ma-
ternal effects usually occur due to the additional mRNAs or proteins passed
from mother to fetus during pregnancy, which may result in an individual
showing the phenotype due to the genotype of the mother regardless of one’s
own genotype.
The first imprinted gene in humans was found almost 20 years ago [Gi-
annoukakis et al. (1993)]. Since then, a number of genetic disorders have
been found to be associated with imprinting defects. The most well known
include Beckwith–Wiedemann syndrome, Silver–Russell syndrome, Angel-
man syndrome and Prader–Willi syndrome [Falls et al. (1999)]. Although it
has been estimated that about 1% of all mammalian genes are imprinted
[Morison, Paton and Cleverley (2001)], only a limited number have been
identified thus far. With the availability of the massively parallel sequencing
technology, scientists are now able to carry out direct studies of imprinting
genomewide in mouse efficiently [Gregg et al. (2010), Wang et al. (2008)].
Nevertheless, the controlled mating setup that was successful in mouse stud-
ies is not feasible in humans. Therefore, there is still a pressing need for the
development of robust and powerful statistical methods for detecting im-
printing effects based on single nucleotide polymorphism data.
A variety of diseases, especially those that are related to pregnancy out-
comes, such as childhood diseases and birth defects, have been hypothesized
to be influenced by maternal effects. Well-known examples of diseases in
which maternal effects play a role include childhood cancer and spina bifida
[Haig (1993, 2004), Jensen et al. (2006)]. Maternal effects are also suspected
to be involved in other diseases such as schizophrenia [Palmer et al. (2006)]
and high blood pressure [Yang and Lin (2009)]. Although imprinting and
maternal effects arise from two different biological processes, their effects as
expressed in the phenotypes can mask one another [Hager, Cheverud and
Wolf (2008)]. Thus, it is important that these two confounding effects be
studied jointly to avoid false positives/negatives.
Two popular designs for studying genomic imprinting and/or maternal
effects are case-parent triads and case-mother pairs, the latter may be sup-
plemented by control-mother pairs [Weinberg, Wilcox and Lie (1998), Wein-
berg and Umbach (2005), Shi et al. (2008), Ainsworth et al. (2011)]. The
use of triads is attractive, as both imprinting and maternal effects can be
studied jointly to handle the issue of confounding. However, it is well known
that fathers are usually much harder to recruit than mothers for a genetic
study, and thus a study design with case-mother/control-mother pairs may
be easier to meeting its target sample size. Nevertheless, the pair design
will lead to reduction in the number of familial genotype categories, and
thus only maternal effect is usually studied even with the assumption of
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mating symmetry [Shi et al. (2008)]. The hybrid design of Vermeulen et al.
(2009) proposed to use control-mother pairs to enrich the sample of case-
parent triads, leading to a case-parent triad/control-mother design. Such a
design increases the number of family genotype categories so that mating
frequencies can be estimated without the mating symmetry assumption.
Both nonparametric and parametric statistical methods have been pro-
posed in the literature for analyzing triads and pairs data. Nonparametric
methods are mainly for detecting the imprinting effect under the assumption
of no maternal effect [Weinberg (1999), Zhou et al. (2009)]. Such methods
are very attractive, as they are simple, elegant and powerful, but they may
suffer from severely inflated type I error rate or power loss if the assumption
is violated. On the other hand, existing parametric methods can usually
study both imprinting and maternal effects (with triad data), but they usu-
ally need to make rather strong assumptions to avoid overparametrization.
The typical assumptions made are regarding mating type probabilities, the
most extreme of which is random mating, leading to the Hardy–Weinberg
equilibrium (HWE). More mild assumptions include parental allelic change-
ability and mating symmetry. It is well accepted that the assumption of
HWE is unlikely to hold, however, even the validity of the least stringent
one, mating symmetry, may still be in doubt in reality. Mating selections are
usually guided by cultural values and social rules in general, and, further,
mating symmetry is easily violated if there is any gender-specific assortative
mating in the population.
Many complex diseases, such as cancers and hypertension, are rather com-
mon. However, rare diseases are sometimes assumed in existing methods so
that the probabilities of child-mother pair genotype combinations can be
treated as approximately the same in the control and in the general pop-
ulations [Shi et al. (2008)]. Although the rationale seems rather intuitive,
analytical as well as simulation results indicate that the rare disease as-
sumption is in fact only a necessary, but not a sufficient condition, for the
frequencies to be roughly equal. It is the interplay of allele frequency and
the underlying genetic model, not the rare disease assumption alone, that
determines whether the pair frequencies are roughly equal.
In this paper, we propose a partial Likelihood approach for detecting
Imprinting and M aternal Effects (LIME) simultaneously using a family-
based case-control design. Specifically, our sampled data is a mixture of case-
parent/control-parent triads and case-mother/control-mother pairs. By in-
cluding control families in our design, we can match case families with control
families of the same structure (i.e., triads vs. triads and pairs vs. pairs) and
factor out common terms involving mating type probabilities, the nuisance
parameters. This design makes it possible to formulate a novel partial like-
lihood approach, wherein the likelihood component of interest is free of the
nuisance parameters. This circumvents the problem of overparametrization
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and unrealistic assumptions that plague existing methods. Further, LIME
can make use of all available data information (complete triads and those
with missing fathers). It does not rely on any assumption about mating type
probabilities or rarity of the disease, which makes it robust to departure from
the usual assumptions without sacrificing much power.
2. Method. The genotype scores (the number of the variant alleles car-
ried by an individual) of the mother, father and child in a triad are denoted
by M , F and C, respectively, which takes values in {0,1,2}. In case-mother
or control-mother pairs, the paternal genotype score F is missing. The dis-
ease status D = 1 indicates that the child is affected and 0 otherwise. We
use the following multiplicative relative risk model of disease penetrance:
P (D = 1|M,F,C)
(1)
= δR
I(C=1)
1 R
I(C=2)
2 R
I(C=1 and origin=M)
im S
I(M=1)
1 S
I(M=2)
2 ,
where δ is the phenocopy rate of the disease; R1 and R2 are the variant allele
effect of 1 and 2 copies carried by the child, respectively; Rim is the effect
when the single copy of the variant allele carried by the child is inherited
from the mother; S1 and S2 are the maternal effect when the mother carries 1
and 2 copies of the variant allele, respectively; and I(·) is the usual indicator
function that is equal to 1 or 0 depending on whether the condition within
the parentheses is met or not. Likelihood ratio tests can be conducted to
test: (1) for association, H0 :R1 =R2 =Rim = S1 = S2 = 1 vs. Ha: at least
one of these parameters is not 1; (2) for (maternal/paternal) imprinting,
H0 :Rim = 1 vs. Ha :Rim(< / >) 6= 1; (3) for maternal effect, H0 :S1 = S2 = 1
vs. Ha :S1 or S2 is not 1. Note that this model was used by Weinberg, Wilcox
and Lie (1998), which was adopted by Shi et al. (2008) but without the term
for the imprinting effect for their pair sampling design. This model is also
equivalent to one of the models used recently by Ainsworth et al. (2011).
Denote the numbers of case-parent triads, control-parent triads, case-
mother pairs and control-mother pairs in the sample by N1t , N
0
t , N
1
p and
N0p , respectively. Two special cases of this general setup are as follows: (1)
N0p = N
1
p = 0, if there are no missing fathers and thus all the families are
triads; and (2) N0t = N
1
t = 0, if all fathers are missing, and thus all the
families are child-mother pairs. Therefore, our method represents a unified
approach as it is applicable to triad only data as in Weinberg, Wilcox and
Lie (1998), or pairs only data as in Shi et al. (2008), or a mixture of the two.
There are 15 possible combinations of (M,F,C) for triads; their enumer-
ation and labeling (type) are listed in the top segment of Table 1. The joint
probability of the disease status of the child (D) and the triad genotype
combination (M,F,C) can be decomposed as
P (D,M,F,C) = P (M,F )P (C|M,F )P (D|M,F,C),
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Table 1
Joint probabilities of disease status and triad genotypesa
Type M F C P (D = 1,M,F,C) P (D = 0,M,F,C)
1 0 0 0 µ00 · 1 · δ µ00 · 1 · [1− δ]
2 0 1 0 µ01 ·
1
2
· δ µ01 ·
1
2
· [1− δ]
3 0 1 1 µ01 ·
1
2
· δR1 µ01 ·
1
2
· [1− δR1]
4 0 2 1 µ02 · 1 · δR1 µ02 · 1 · [1− δR1]
5 1 0 0 µ10 ·
1
2
· δS1 µ10 ·
1
2
· [1− δS1]
6 1 0 1 µ10 ·
1
2
· δS1R1Rim µ10 ·
1
2
· [1− δS1R1Rim]
7 1 1 0 µ11 ·
1
4
· δS1 µ11 ·
1
4
· [1− δS1]
8 1 1 1 µ11 ·
1
4
· δS1R1(1 +Rim) µ11 ·
1
4
· [2− δS1R1(1 +Rim)]
9 1 1 2 µ11 ·
1
4
· δS1R2 µ11 ·
1
4
· [1− δS1R2]
10 1 2 1 µ12 ·
1
2
· δS1R1 µ12 ·
1
2
· [1− δS1R1]
11 1 2 2 µ12 ·
1
2
· δS1R2 µ12 ·
1
2
· [1− δS1R2]
12 2 0 1 µ20 · 1 · δS2R1Rim µ20 · 1 · [1− δS2R1Rim]
13 2 1 1 µ21 ·
1
2
· δS2R1Rim µ21 ·
1
2
· [1− δS2R1Rim]
14 2 1 2 µ21 ·
1
2
· δS2R2 µ21 ·
1
2
· [1− δS2R2]
15 2 2 2 µ22 · 1 · δS2R2 µ22 · 1 · [1− δS2R2]
P (D = 1,M,C) P (D = 0,M,C)
1, 2 0 − 0 (µ00 +
1
2
µ01) · δ (µ00 +
1
2
µ01) · [1− δ]
3, 4 0 − 1 ( 1
2
µ01 + µ02) · δR1 (
1
2
µ01 + µ02) · [1− δR1]
5, 7 1 − 0 ( 1
2
µ10 +
1
4
µ11) · δS1 (
1
2
µ10 +
1
4
µ11) · [1− δS1]
6, 8, 10 1 − 1 1
2
µ10 · δS1R1Rim
1
2
µ10 · [1− δS1R1Rim]
+ 1
4
µ11 · δS1R1(1 +Rim) +
1
4
µ11 · [2− δS1R1(1 +Rim)]
+ 1
2
µ12 · δS1R1 +
1
2
µ12 · [1− δS1R1]
9, 11 1 − 2 ( 1
4
µ11 +
1
2
µ12) · δS1R2 (
1
4
µ11 +
1
2
µ12) · [1− δS1R2]
12, 13 2 − 1 (µ20 +
1
2
µ21) · δS2R1Rim (µ20 +
1
2
µ21) · [1− δS2R1Rim]
14, 15 2 − 2 ( 1
2
µ21 + µ22) · δS2R2 (
1
2
µ21 + µ22) · [1− δS2R2]
aM , F and C are the number of variant allele(s) carried by the mother, the father and the
child in a family, which are equal to 0, 1 or 2; F =− indicates paternal genotype is missing
in case-mother and control-mother pairs; µmf denotes the probability of parental pairs in
which the mothers carry m copies and the fathers carry f copies of the variant allele, that
is, mating type probability of (M,F ) = (m,f); δ is the phenocopy rate of the disease in
the population; R1 and R2 are relative risks due to 1 and 2 two copies of the variant allele
carried by the offspring, respectively; Rim is the relative risk due to the single copy of the
variant allele being inherited from the mother; S1 and S2 are the maternal effect of 1 and
2 copies of the variant allele carried by the mother, respectively.
where P (M,F ) is the population probability of a particular parental pair
(also called mating type), which is denoted by µmf for M =m and F = f .
Note that we do not make any assumption about the mating type probabili-
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ties such as HWE or even mating symmetry, and thus µmf is not necessarily
equal to µfm. On the other hand, P (C|M,F ) is the transmission probability,
which follows the Mendelian law of segregation. For the penetrance proba-
bility, P (D|M,F,C), we use the multiplicative relative risk model as given
in equation (1). For all types other than type 8 (Table 1), if a child has one
copy of the variant allele, the parental origin can be unambiguously ascer-
tained, and hence the relevant factors can be easily extracted from (1) and
multiplied to the joint probability. For type 8, in which (M,F,C) = (1,1,1),
the variant allele carried by the child can be inherited either from the mother
or the father with equal probabilities and, as such, both possibilities need
to be considered, leading to the summation of two probabilities weighted
equally. For all 15 types, the specific joint probabilities for the case-parent
and control-parent triads are given in the last two columns of the top seg-
ment of Table 1. We can see from the table that the parameters concerning
the mating type probabilities (µmf ) are factored out nicely from the param-
eters of the disease model, both for the case and the control families.
For pairs, because the father’s genotype is missing, the 15 (M,F,C) com-
binations for triads collapse into 7 (M,C) types, as indicated in the bottom
segment of Table 1. In other words, each (M,C) type is the combination
of potential triad types had the paternal genotype been observed for those
child-mother pairs. For example, for (M,C) = (0,0), the father’s genotype
can be either 0 or 1 and, therefore, the first type for (M,C) is the com-
binations of types 1 and 2 for triads. Accordingly, the joint distribution of
disease status and genotype is the sum of the probabilities of the collapsing
triads types. That is,
P (D,M,C) =
∑
F=0,1,2
P (D,M,F,C) =
∑
F=0,1,2
P (M,F,C)P (D|M,F,C),
where P (M,F,C) may be 0 if F is not compatible with the observed geno-
types. For example, for (M,C) = (0,0), F = 2 is incompatible and, there-
fore, the summation is only over 0 and 1. For most (M,C) combinations,
the penetrance P (D|M,F,C) can be factorized out of the summation over
F = 0,1,2, since the penetrance is the same for the potential types of triad
regardless of the paternal genotype under our model. The only exception is
(M,C) = (1,1), in which case the penetrance term is different for the three
potential types of triad unless the imprinting effect is absent (i.e., Rim = 1).
The specific joint probabilities for the case-mother and control-mother pairs
are given in the last two columns of the bottom segment of Table 1. We
can see from the table that, other than when (M,C) = (1,1), the parame-
ters concerning the mating type probabilities (µmf ) are factored out nicely
from the parameters of the disease model, both for the case and the control
families.
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Denote the counts of case-parent and control-parent triads with M =m,
F = f and C = c by n1mfc and n
0
mfc, respectively. Similarly, the counts of
case-mother and control-mother pairs withM =m and C = c are denoted by
n1mc and n
0
mc. With the fixed totals N
1
t , N
0
t , N
1
p and N
0
p , the distributions
of the 15 observed triad counts for the cases ({n1mfc}) and the controls
({n0mfc}), and those of the 7 observed pair counts for the cases ({n
1
mc}) and
the controls ({n1mc}), are as follows:
n1mfc ∼Multinomial(N
1
t , P (M =m,F = f,C = c|D = 1)),
n0mfc ∼Multinomial(N
0
t , P (M =m,F = f,C = c|D = 0)),
n1mc ∼Multinomial(N
1
p , P (M =m,C = c|D = 1)),
n0mc ∼Multinomial(N
0
p , P (M =m,C = c|D = 0)).
The cell probabilities P (M,F,C|D) = P (D,M,F,C)/P (D) and P (M,C|D) =
P (D,M,C)/P (D), where the probabilities in the numerators are as given in
Table 1 and we assume the disease prevalence, P (D = 1), in the source pop-
ulation is known. Such information for most known diseases can be retrieved
from the Incidence and Prevalence Database (IPD) (http://www.tdrdata.com/
IPD/ipd init.aspx) or other sources.
The likelihood function of our observed data is as follows:
P (n1mfc, n
0
mfc, n
1
mc, n
0
mc|µmf , δ,R1,R2,Rim, S1, S2)
∝
∏
(m,f,c)
P (M =m,F = f,C = c|D = 1)n
1
mfc
× P (M =m,F = f,C = c|D = 0)n
0
mfc
×
∏
(m,c)6=(1,1)
P (M =m,C = c|D = 1)n
1
mcP (M =m,C = c|D = 0)n
0
mc
∝
{ ∏
(m,f,c)
(pmfc)
n1
mfc(1− pmfc)
nmfc−n
1
mfc
×
∏
(m,c)6=(1,1)
(pmc)
n1mc(1− pmc)
nmc−n
1
mc
}
×
{ ∏
(m,f,c)
[smfcP (M =m,F = f,C = c)]
nmfc
×
∏
(m,c)6=(1,1)
[smcP (M =m,C = c)]
nmc
}
,
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where nmfc = n
0
mfc + n
1
mfc and nmc = n
0
mc + n
1
mc. Further,
smfc =N
1
t P (D = 1|m,f, c)/P (D = 1) +N
0
t P (D = 0|m,f, c)/P (D = 0),
smc =N
1
pP (D = 1|m,c)/P (D = 1) +N
0
pP (D = 0|m,c)/P (D = 0),
pmfc =
N1t P (D = 1|m,f, c)/P (D = 1)
smfc
,
pmc =
N1pP (D = 1|m,c)/P (D = 1)
smc
.
Note that the above expressions are independent of the nuisance parame-
ters (mating type probabilities µmf ), as we will see more clearly, from the
derivation of the formula below, the nuisance parameters in the numerator
and denominator cancel out.
In our likelihood formulation, note that the pair type (1,1) is not included
since the nuisance parameters and the risk parameters cannot be nicely
separated as discussed above. The potential effects of excluding this data
type will be addressed in the discussion section. With this exclusion, one
can see from the above factorization that only the second component of the
likelihood (factors within the second set of curly brackets in the last formula)
contains the nuisance parameters µmf ’s. Therefore, the first component is
our partial likelihood, which can be maximized instead of the full likelihood
to avoid estimating the nuisance parameters [Cox (1975)]. In fact, the partial
likelihood component can be regarded as the likelihood of the reorganized
data conditional on each possible triad (M,F,C) or pair (M,C) type. Within
each type, counts of the cases and controls follow a “renormalized” binomial
distribution with the appropriate probabilities. For example, for a triad type
(m,f, c), the probabilities of observing a case are
pmfc =
E(n1mfc)
E(n1mfc + n
0
mfc)
=
N1t P (m,f, c|D= 1)
N1t P (m,f, c|D= 1) +N
0
t P (m,f, c|D = 0)
=
N1t P (D = 1|m,f, c)/P (D = 1)
N1t P (D = 1|m,f, c)/P (D = 1) +N
0
t P (D = 0|m,f, c)/P (D = 0)
.
This manipulation turns data from a retrospective design into a “prospec-
tive” likelihood stratified according to each type. That is, the partial like-
lihood is the kernel of Binomial(nmfc, pmfc) and Binomial(nmc, pmc), and
nmfc and nmc may be viewed as “fixed” as in a binomial distribution. Thus,
although the second component of the likelihood contains the parameters
of interest, it does not depend on the data. It is also worth reemphasizing
that, by modeling the counts using partial likelihood instead of the full like-
lihood, the dimensionality of the parameter space is greatly reduced. Only
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phenocopy rate and genotype relative risks are estimated from the partial
likelihood. Consequently, no assumption is needed regarding the underlying
mating type probabilities in the population.
3. Two existing methods for comparison.
3.1. Constrained log-linear model. A special case of our family case-
control design, in which N1t = N
0
t = 0, was considered in a recent study
[Shi et al. (2008)] to detect maternal effects. They used the log-linear rela-
tive risk model for the case-mother and control-mother pairs, but assuming
the absence of imprinting. Thus, their model is a special case of our model
as specified in (1) by setting Rim = 1. However, since their full likelihood
approach requires the estimation of mating type probabilities, they propose
to explore three levels of assumptions regarding these probabilities, namely,
Mendelian inheritance, mating symmetry and parental allelic exchangeabil-
ity, leading to what they call a constrained log-linear model (CLL).
In addition to the assumption about mating type probabilities, the ex-
pected frequencies of control-mother pairs were assumed to be the same as
the expected frequencies of any child-mother pairs for each type regardless of
whether the child is affected or not. Considering the retrospective nature of
the case-mother/control-mother design, the fact that the child in a control-
mother pair is unaffected should be taken into account by multiplying the un-
affected probability by the expected frequency of each (M,C) combination.
Unless the conditional probability of being unaffected given every (M,C)
combination is close to 1, approximating the frequencies of control-mother
pairs using the frequencies of child-mother pairs in the general population
would be inaccurate. Shi et al. (2008) justified the use of this approximation
under the rare disease assumption. This assumption only implies that the
marginal unaffected probability in the whole population is close to 1, but
the conditional unaffected probability given some of the (M,C) type may
not be close to 1 at all. In particular, when (M,C) = (2,2), the conditional
probability that the child is unaffected, 1− δS2R2, might be much smaller
than 1 for reasonably large relative risks S2 and R2. For example, suppose
the phenocopy rate δ = 0.05, and the relative risks are S2 = 2 and R2 = 3
as in one of the settings in Shi et al. (2008), then 1 − δS2R2 is only 0.7.
Thus, although the rare disease assumption is necessary, it is certainly not
sufficient in justifying the frequency approximation used in CLL.
A careful dissection of CLL reveals that the control-mother expected
frequencies approximation was also needed for the mating type probabil-
ity assumption under Mendelian inheritance. It is indeed true that, under
Mendelian inheritance, the sum of the expected frequencies of child-mother
pairs with (M,C) = (1,0) and with (M,C) = (1,2) equals the expected fre-
quency with (M,C) = (1,1) if the pair is randomly sampled from the pop-
ulation. However, this does not hold for control-mother pairs due to the
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Table 2
Simulation settings of the relative risks
Settings
Parameter 1 2 3 4 5 6 7 8
R1 1 2 1 1 1 3 1 3
R2 1 3 3 3 3 3 3 3
Rim 1 1 1 1 3 1/3 3 1/3
S1 1 1 1 2 1 1 2 2
S2 1 1 1 2 1 1 2 2
involvement of unaffected probabilities as discussed above, which compli-
cates the simple relationship in the constraint.
3.2. Log-linear likelihood ratio test. The log-linear likelihood ratio test
(LL-LRT) was the first method proposed for detecting imprinting and ma-
ternal effects simultaneously using case-parent triad data [Weinberg, Wilcox
and Lie (1998)]. It assumes multiplicative relative risks and models the
counts of the 15 case-parent triads using a log-linear model as in (1). It
is necessary to make the assumption of mating symmetry when using LL-
LRT; otherwise, the number of parameters in the model would exceed the
degrees of freedom of the count data.
4. Simulation. To evaluate the performance of the proposed method and
to compare it with the existing methods, we create 8 simulation settings of
the relative risks due to variant allele, imprinting and maternal effects (Ta-
ble 2). The first 4 settings with the imprinting relative risk being equal to
1 (i.e., no imprinting effect) are the same as the simulation settings in Shi
et al. (2008). Settings 5 and 6 have paternal and maternal imprinting effects,
respectively, but no maternal effect. Settings 7 and 8 have paternal and ma-
ternal imprinting effects, respectively, and also maternal effect. Prevalence
of the disease is set to be 0.05 (rare) or 0.15 (common). Note that the sum-
mation over the 15 joint probabilities P (D = 1,M,F,C) equals the disease
prevalence P (D = 1), and thus the phenocopy rate can be solved from the
equation since relative risks and prevalence are set in our simulation and the
phenocopy rate is the only unknown quantity.
We consider three variant allele frequencies (VAF), 0.1, 0.3 and 0.7, and
simulate the parental genotypes under two scenarios. Under the first sce-
nario, the population is in HWE and the probabilities of a paternal or
maternal genotype score being 0, 1 and 2 are (1 − p)2, 2(1 − p)p and p2,
respectively, where p is the variant allele frequency, p ∈ {0.1,0.3,0,7}. Since
the population is in HWE, allelic exchangeability (AE) and mating sym-
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metry (MS) are implied. In the other scenario, the probabilities of a geno-
type score being 0, 1 and 2 are (1− p)2(1− ζ) + (1− p)ζ , 2p(1− p)(1− ζ)
and p2(1− ζ) + pζ , respectively, where ζ is the inbreeding parameter [Weir
(1996)], which is set to be 0.1 and 0.3 for males and females, respectively. As
such, neither AE nor MS holds in the population under the second scenario.
For each triad, the genotype of the child is sampled according to the
transmission probability given the previously simulated parental genotypes,
and then the disease status is generated as a Bernoulli trial with the success
probability being equal to the phenocopy rate multiplied by the relevant
relative risks. This process is repeated until 150 case-parent triads and 150
control-parent triads are obtained. This sample size was chosen to be the
same as in Shi et al. (2008) to facilitate comparison. We then count the 15
types of child-parent triads among case families and control families. Ignor-
ing all the fathers, we also count the 7 types of child-mother pairs among
case families and control families. Finally, we also create a mixture sample
of triads and pairs by randomly setting the father’s genotype to be miss-
ing with probability 0.5 in each triad. This last setting allowing for missing
paternal genotype is the most realistic in genetic epidemiology studies. The
number of replication for each simulation setting is set to be 1000.
LIME is applied to the pair/triad mixture counts (LIME-mix). CLL is
applied to the pairs (150 case-mother pairs and 150 control-mother pairs)
with the constraint arising from AE. Since CLL models pair counts and does
not consider the imprinting effect, LIME is also applied to pair counts with-
out the imprinting effect (LIME-pair) purely for the purpose of comparison
with CLL. On the other hand, LL-LRT is applied to the case-parent triads
(150 complete case-parent triads). The simulation results are summarized
in the following three subsections.
4.1. Bias. Relative bias of a parameter estimate is defined as (θˆ− θ)/θ,
where θˆ is the estimate of θ and θ ∈ {R1,R2,Rim, S1, S2} as given in the mul-
tiplicative relative risk model. The scatterplots shown in Figure 1(a) are rela-
tive biases of LIME-pair versus relative biases of CLL. Since neither CLL nor
LIME-pair models imprinting effect, it is only appropriate to compare their
biases under the settings in which the imprinting effect is absent. Hence, each
panel in Figure 1(a) plots the biases of Rˆ1, Rˆ2, Sˆ1 and Sˆ2 under the first 4
simulation settings of the relative risks. The columns of panels in Figure 1(a)
correspond to the three variant allele frequencies, while the rows correspond
to the four combinations of the two prevalence settings (0.05 and 0.15) and
whether AE holds. Recall that AE is the constraint imposed in CLL.
The scatterplots shown in Figure 1(b) are relative biases of LIME-mix
versus relative biases of LL-LRT. Since both LIME-mix and LL-LRT model
variant allele, imprinting and maternal effects simultaneously, each panel
plots the biases of Rˆ1, Rˆ2, Rˆim, Sˆ1 and Sˆ2 under all 8 simulation settings.
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Fig. 1. Relative estimation biases of (a) LIME-pair versus CLL and (b) LIME-mix
versus LL-LRT. In both figures (a) and (b), three variant allele frequencies (VAF) are
considered and plotted in the three columns. Further, population 1 is in HWE, such that
both AE and MS hold, whereas neither AE nor MS holds in population 2. The four
rows in the figures correspond to the four combinations of population (1 or 2) and dis-
ease prevalence (rare: 0.05 or common: 0.15): row 1: population = 1, prevalence = 0.05;
row 2: population= 1, prevalence= 0.15; row 3: population= 2, prevalence = 0.05; row 4:
population= 2, prevalence = 0.15.
Thus, there are more points in Figure 1(b) than in Figure 1(a). The rows of
Figure 1(b) correspond to the four combinations of the prevalence settings
and whether AE holds. Note that AE implies MS, an assumption made in
LL-LRT.
The intersecting dotted diagonal lines in each panel divide the square
into 4 triangular regions. Scattering points in the left and right triangles
correspond to the relative biases on the y-axis (LIME-pair/LIME-mix) being
smaller than the relative biases on the x-axis (CLL/LL-LRT) in absolute
magnitude. In both Figures 1(a) and (b), almost all the points are scattering
in the left/right triangle in each panel, which indicates the smaller relative
biases of LIME-pair and LIME-mix under all circumstances simulated. When
the AE/MS does not hold [3rd and 4th rows of both Figures 1(a) and (b)],
the relative biases of CLL/LL-LRT become larger, a phenomenon also noted
in Sinsheimer, Palmer and Woodward (2003). In contrast, the relative biases
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of LIME-pair/Lime-mix remain at around the same level, which is close to
zero.
When AE actually holds, the relative biases of CLL become a bit larger
when the prevalence changes from 0.05 to 0.15, which reflects the rare disease
assumption being necessary (though not sufficient) for CLL to be valid.
When both the rare disease (prevalence = 0.05) and AE assumptions hold
but the variant allele frequency is small (VAF = 0.1), CLL still has some
large relative biases, which mainly correspond to the estimates of R2 and
S2. When the VAF is small, it is likely that there is no child-mother pairs
with (M,C) = (2,2) in the sample. The zero cell count due to small VAF
leads to large estimation variability for these two parameters. This can also
be observed from the large relative biases of LL-LRT in estimating R2 and S2
when VAF is small, which are due to the zero counts for (M,F,C) = (2,1,2)
and (2,2,2).
4.2. Type I error rate and power. Figure 2 presents the type I error rates
and power of CLL, LIME-pair, LIME-mix and LL-LRT under the 8 simu-
lation settings of relative risks. The vertical dotted lines divide each panel
into 4 regions, from left to right, corresponding to (1) prevalence = 0.05 and
AE hold; (2) prevalence = 0.15 and AE hold; (3) prevalence = 0.05 but nei-
ther AE nor MS holds; (4) prevalence = 0.15 but neither AE nor MS holds.
Type I error rates are shown in the gray panels with a horizontal dashed line
marking the nominal level of 0.05, while other panels show power. Type I er-
ror rates and power of CLL and LIME-pair are absent in the middle rows of
the panels, since neither CLL nor LIME-pair includes the imprinting effect.
4.2.1. Settings 1–4. The imprinting effect is absent in simulation settings
1–4. Type I error rates for detecting the imprinting effect using LIME-mix
and LL-LRT are all around the nominal level of 0.05. For detecting asso-
ciation and maternal effect, CLL and LL-LRT have inflated type I error
rates in regions (3) and (4), in which neither AE nor MS holds, whereas
LIME-pair and LIME-mix have correct type I error rates under all circum-
stances. The powers of CLL and LIME-pair are higher than LIME-mix and
LL-LRT, not surprisingly, since CLL and LIME-pair do not attempt to es-
timate the nonexisting imprinting effect and thus are more efficient. The
power of CLL is higher than or about the same as LIME-pair in regions
(1) and (2), in which AE holds and is correctly incorporated into CLL as
a parameter constraint. However, the power of CLL is lower than that of
LIME-pair in regions (3) and (4) under setting 3, a case in which the power
for CLL is reduced because the constraint is wrongly imposed when the as-
sumption does not hold. CLL has higher power than LIME-pair in setting 4
for detecting maternal effect. The power of LIME-mix is always higher than
that of LL-LRT in detecting association and maternal effect in these four
settings.
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Fig. 2. Type I error rates and power of CLL, LIME-pair, LIME-mix and LL-LRT. Pan-
els with gray background give type I error rates, whereas the rest show power. The ver-
tical dotted lines divide each panel into 4 regions corresponding to, from left to right:
(1) prevalence = 0.05, AE and MS holds; (2) prevalence = 0.15, MS and AE hold; (3)
prevalence = 0.05, neither AE nor MS holds; (4) prevalence = 0.15, neither AE nor MS
holds. Columns 1–8 correspond to the 8 simulation settings of relative risks in Table 2.
4.2.2. Settings 5–8. The imprinting effect is present in the simulation
settings 5–8, and maternal effect is present in the latter two settings. Under
settings 5 and 6, CLL and LIME-pair have a lot of false positives for maternal
effects that are actually due to the imprinting effect because of confounding
[Hager, Cheverud and Wolf (2008)]. LL-LRT also has inflated type I error
rates in regions (3) and (4) due to its MS assumption being violated, whereas
LIME-mix has correct type I error rates in all regions. Due to the strong
association signal in these four settings, all four methods have about the
same power in detecting association. LL-LRT has higher power in detecting
the imprinting effect than LIME-mix, but LIME-mix has higher power in
detecting maternal effect than LL-LRT. Due to the confounding between im-
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printing and maternal effect, the paternal imprinting in setting 7 “magnifies”
the signal of maternal effect if imprinting effect is not properly accounted for.
As such, CLL and LIME-pair have a higher power for detecting the maternal
effect, but they miss the imprinting effect completely. On the other hand,
setting 8 depicts maternal imprinting, and thus CLL and LIME-pair have
a lower power for detecting the “reduced” maternal effect. This represents
the worse case scenario; not only is the imprinting effect missed completely
but there is also reduced power for detecting maternal effect.
4.3. Sensitivity analysis. Since the proposed method LIME-mix needs
the disease prevalence in the population as a known constant, we conduct a
sensitivity analysis to investigate the impact of using a misspecified preva-
lence in our model. A constant that is 5% higher, 5% lower, 20% higher or
20% lower than the true prevalence in the simulation setting is used as the
prevalence in LIME-mix. The mixtures of triads/pairs simulated under the 8
settings of relative risks are analyzed again using LIME-mix with these inac-
curate prevalences. Relative biases of LIME-mix using inaccurate prevalence
are plotted versus relative biases of LIME-mix using the true prevalence in
Figure 3.
When the disease is rare (with a true prevalence of 0.05), we can see from
Figure 3(a) that all points fall almost exactly on the dashed line with slope
1, indicating that the estimates of the relative risks using the inaccurately
specified prevalence are actually very close to those using the true preva-
lence. That is, the results are rather insensitive to the misspecification of
population prevalence. On the other hand, when the disease is more com-
mon (true prevalence being 0.15), the points still scatter around the dashed
line with slope 1, as we can see from Figure 3(b), although there is more scat-
tering when the prevalence is incorrectly specified to be 20% higher/lower
than the true value. Overall, the results are reasonably insensitive to the
specification of population prevalence. Estimated prevalences are often ob-
tained through large scale population studies and would, in those cases, not
deviate greatly from their true values. As such, our results seem to suggest
that LIME would give reasonably accurate estimates by using population
prevalences estimated from external sources when the same population and
diagnostic criteria have been studied.
5. Discussion. In this paper we propose a partial likelihood approach for
detecting imprinting and maternal effects simultaneously using case-control
families. The crucial role played by imprinting and maternal effects in com-
plex human diseases has been increasingly explored in the last few years,
as simply focusing on sequence variation has been proven to be insufficient
for studying disease etiology. As such, there is an immediate need for ro-
bust and efficient statistical methods for detecting imprinting and maternal
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Fig. 3. Sensitivity analysis of the bias with a misspecified prevalence when (a) the true
prevalence = 0.05 (rare disease) and (b) the true prevalence = 0.15 (common disease). In
both figures (a) and (b), three variant allele frequencies (VAF) are considered and plotted
in the three columns. The four rows correspond to four different misspecified prevalences.
Row 1: prevalence is 5% higher than the true value; row 2: prevalence is 5% lower than
the true value; row 3: prevalence is 20% higher than the true value; row 4: prevalence is
20% lower than the true value.
effects, and our contribution is one step in this direction. Our proposed
method possesses a number of novel features compared to existing ones in
the literature. We augment the traditional case-parent triads design to a
family-based case-control design by recruiting control-parent triads as well.
This differs from Weinberg and Umbach (2005) in that they only genotype
the parents of the controls, leading to a case-parent triad/control-parent
design. Further, we allow for missing fathers considering the fact that fa-
thers are often harder to recruit in family-based studies. Thus, this design
also differs from that of Vermeulen et al. (2009), as the current design also
recruits control-parent triads and case-mother pairs. By recruiting control
families of the same structure as case families, we create “internal matches”
stratified by the familial genotypes. As such, we can extract from the full
likelihood of the retrospective design a partial likelihood component that
can be thought of as the products of likelihoods from stratified prospective
designs. Through this conditional on the familial genotypes, the nuisance
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parameters with respect to the population mating type probabilities (i.e.,
probabilities of parental genotype combinations) are no longer involved in
the partial likelihood. As such, it is no longer necessary to make any as-
sumption about mating type probabilities; such assumptions are strong and
usually unrealistic but are made in the literature in an effort to reduce the
number of parameters for the full likelihood approach. This alleviates the
problem of over-parametrization that often plagues existing methods. Fur-
thermore, our formulation takes into account the fact that control families
have unaffected children, making it applicable to both rare and common dis-
eases as opposed to just rare diseases in some existing methods. However,
we note that the mother-child data type in which both the mother and the
child are heterozygotes cannot be included in the analysis, an issue that will
be discussed further below.
Through simulation with a variety of settings, including some adopted
from the literature, we demonstrate the robustness of LIME to violation of
assumptions on absence of imprinting effects, rarity of disease and mating
type probabilities. First, by utilizing a mixture of case/control triad fami-
lies and case/control pair families, imprinting and maternal effects can be
studied jointly to address the confounding issue faced by approaches that
assume the absence of imprinting effect when detecting maternal effects. As
such, LIME has correct type I error rate compared to those approaches. If,
however, there is a priori and unequivocal information that imprinting ef-
fect is indeed absent, then a method that assumes the absence of imprinting
effect will usually lead to gain in power for detecting maternal effect. In this
situation, a version of LIME that assumes the absence of imprinting (by
setting Rim = 1) is recommendable given its robust and efficient features.
Second, regardless of whether the disease is common or rare, LIME has
very little bias in the estimates of the model parameters. In contrast, CLL,
which assumes the disease being rare, has much larger biases, even when the
disease is indeed rare, since rare disease is a necessary but not a sufficient
condition for CLL to be valid.
Finally, mating symmetry is commonly assumed for many imprinting
and/or maternal effects detection methods [Ainsworth et al. (2011), Shi
et al. (2008), Weinberg, Wilcox and Lie (1998), Weinberg (1999), Zhou et al.
(2009)]. However, when this assumption is violated, there can be large bi-
ases and greatly inflated type I error rates, whereas LIME is not affected
at all by departure from such assumptions (Figures 1 and 2). In particular,
when there is population substructure, the assumption of HWE is violated
even if there is HWE in each of the subpopulations. Therefore, population
substructure will likely exert a large effect on methods that assume some
mating frequency distributions. In contrast, because the partial likelihood
is independent of the mating type parameters, LIME may not be as sensi-
tive to such population substructure. The non-HWE scenario considered in
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our simulation may be viewed as a mixture of two subpopulations, one is in
HWE and the other is inbred. Indeed, CLL and LL-LRT are highly sensitive,
whereas LIME is robust to this type of population stratification. However,
will LIME still be robust if the disease prevalences also differ in the sub-
populations? To investigate this, we consider the following three scenarios
of population substructure in which a population consists of two distinct
subpopulations each in HWE: (a) the two populations differ in their allele
frequencies (VAF = 0.1 or 0.3) but with the same disease prevalence of 0.05;
(b) the two populations have the same allele frequency (VAF = 0.3) but
different prevalences (0.05 or 0.15); (c) the two populations have different
allele frequency (VAF = 0.1 or 0.3) and also different prevalences (0.05 or
0.15). Under disease risk settings 1–4 (Table 2; imprinting absence), LIME
has smaller relative biases in all parameter estimates and smaller type I er-
ror rates under all scenarios, and they are smaller (some are much smaller)
than those from CLL. For disease settings 5–8 (Table 2; imprinting present),
LIMEs estimates have larger biases, especially for scenario (b), but they are,
in the majority of cases, much smaller than those from CLL. This indicates
that LIME is sensitive to population stratification when there is imprinting
effect, but it is certainly more robust than the alternative method even un-
der the situation where the disease prevalences are different in addition to
different frequencies in the subpopulations.
To compare with the performance of CLL, we consider LIME-pair in addi-
tion to LIME-mix. In real data applications, only LIME-mix will be used un-
less there are no triads in the sample (i.e., all the fathers are missing in all the
families). This is an unlikely scenario, but if this does happen, then LIME-
pair is recommendable over CLL due to its robust feature, although we note
that LIME-pair, like CLL, also assumes the absence of imprinting effect.
The need to specify disease prevalence deserves further discussion. Since
the prevalence is in fact a function of the disease model parameters and
mating type probabilities, it would be attractive if one can make use of this
fact without the need to specify this parameter. However, in order to use the
current argument, the partial likelihood needs to be free of the mating type
probabilities, which will no longer be true if we express P (D) in terms of
the other parameters. Fortunately, as we have pointed our earlier, estimated
prevalences are often obtained through large scale population studies and
would usually not deviate greatly from their true values. Overall, even if
the prevalence is misspecified as much as 20% away from the true value,
the estimates are still quite close to those had the prevalence been specified
correctly, reaffirming the robustness of the proposed procedure. However, for
rarer diseases, the deviations between the true and estimated prevalences
may be larger. Thus, we further investigate the effect of greater prevalence
misspecification for a disease with a prevalence of 1%. We use a prevalence
of 0.2%, 5% (representing 500% decrease or increase) and 0.8%, 1.2% (20%
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decrease or increase). Our results show that LIME remains robust with
a 20% increase/decrease misspecification. Even with a 500% decrease, the
parameter estimates closely track those using the true prevalence. A 500%
increase leads to more sensitivity, but the procedure is still quite robust if
the variant allele frequency is moderate.
In LIME, the mother-child data type in which both the mother and the
child are heterozygous—the (1,1) data type—is not included in the analysis
since the nuisance parameters are tangled up with the risk parameters of
interest (Table 1), and therefore its inclusion will render it impossible to
adopt the partial likelihood approach. This exclusion, however, will lead to
loss of information. Since we cannot evaluate its effect on LIME directly, we
use CLL as a surrogate by analyzing the data without the (1,1) data type
and compare the results with those from the earlier analysis where (1,1) is
included. The power is slightly lower for most of the tests, although power
actually increases for some; overall, the average power drop is 0.056, small
but appreciable. This amount may be viewed as an upper bound; the effect
on LIME is expected to be much smaller unless most of the data are from
pairs, not triads. This finding of small effect is not surprising considering
the parent asymmetry test (PAT) of Weinberg (1999). Therein, five triad
categories, including (1,1,1) (all three people in the family are heterozy-
gous), were omitted from the model, but PAT is competitive in power for
imprinting test compared to methods that use all categories.
Although fathers are usually harder to recruit than mothers, this does
not imply 100% participation rate from mothers. As such, there will likely
be child-father pairs in a study as well, but such data cannot be utilized
in our partial likelihood approach since the model parameters and nuisance
parameters cannot be factored as in child-mother pairs.
Finally, in this paper we assume a single affected child for each case fam-
ily. In genetic diseases, there may be familial aggregation and, therefore, it
is not unlikely that there may be multiple affected siblings in a family. If
each family is being recruited through single ascertainment (i.e., through
an affected/unaffected child), then additional information from the siblings
(even from the control families) may be used in the partial likelihood formu-
lation. This may lead to substantial power gain, and thus warrants further
investigation.
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